This White Paper draws on the expertise of 10 senior Medical Affairs leaders across diverse global organizations to describe the role of Medical Affairs in ensuring the MedTech industry meets the challenges of high-quality evidence, objective measures, changes in the healthcare landscape, and more.
The volume of published Medical Information is doubling every 70-75 days and Medical Affairs teams tasked with disseminating and generating new evidence are facing more channels and sources of competition to reach and educate health care providers than ever before. This expert panel discussion will showcase innovative applications of internal performance management platforms such as the Medical Productivity Index (MPI) and external events, namely the 2022 Medical Affairs Innovation Olympics in pharma that illustrate examples of more continuous, real time feedback on performance, new data science analytics driven analysis of performance, more even distribution of accountability, and increased resources to accelerate learning and development. In addition, the webinar will explore both pharma and diagnostics strategies to explain how innovative performance management approaches translate into improved healthcare access and outcomes by analyzing patient and provider level data across internal functions and external institutions.
In today’s episode, we’ll be looking at considerations for Medical Affairs in Rare Disease and Gene Therapy
The transformation is happening now. Discover how Medical Affairs teams are evolving from an executional hub to a strategic pillar, resonating and reconciling the voice of the patient and clinicians, and driving insights to their organization. Using the MAPS Medical Affairs Vision 2030 as our roadmap, experts will discuss the criticality of:
This White Paper provides a foundational understanding of insights management, including the definition and value of insights, processes and technologies for insights management, and key challenges in implementation.
Medical Affairs is increasingly playing a mission-critical role in bringing novel medicines to patients and working as a value-adding partner with R&D and commercial functions in pharma. In this webinar, a roundtable of experienced Medical Affairs leaders will discuss the opportunities and challenges evolving within their field, as well as the impact it can have on delivering great patient outcomes. The webinar will also explore how, while operating at an asset, above-asset and company-mission level, Medical Affairs can act as an organizational lead across the diverse areas of insight and evidence generation, scientific communication and engagement, patient advocacy and more.
In this webinar, we will show the views from a Therapeutic Area Lead responsible for establishing the insight objectives and ensuring action; a Field Medical Lead responsible for collecting and processing insights data; and a Strategic Program & Innovation Lead responsible for building & managing the program as well as ensuring actionable insight communication.
The objectives of this webinar are to present alternate views on a particular issue that is of concern to the Medical Affairs community while also attempting to resolve the issue.
This article outlines the aspects of Medical Affairs strategy and launch excellence specific to supporting the development and launch of treatments targeting rare diseases, providing a roadmap for MA teams and organizations undertaking this planning.
In this episode, MAPS speaks with Mark Michalski, former radiologist and currently Worldwide Head, Healthcare & Life Sciences, Artificial Intelligence and Machine Learning, Amazon Web Services about how we can catch up with big tech in our ability to mine data for meaning.